Literature DB >> 18468793

Increase in bax expression and apoptosis are associated in Huntington's disease progression.

A V F F Teles1, T R Rosenstock, C S Okuno, G S Lopes, C R A Bertoncini, S S Smaili.   

Abstract

Huntington's disease (HD) is a hereditary dominant neurodegenerative disorder and the progression of the disease may be associated with apoptosis and altered expression of apoptotic proteins. The aim of this study was to investigate gene expression of bax and bcl-2 in tissues from R6/1 transgenic (TGN) mice of different ages (3, 6 and 9 months). The mRNA expression was investigated and related to apoptotic cells measured by TUNEL. Results showed a significant and progressive increase in bax levels in the cortex of TGN (from 10 to 33%) when compared to control (CT) (8 to 20%) mice with 3, 6 and 9-month-old. The increase in bax was correlated with the elevation in the number of apoptotic nuclei, especially in the cortex of 6 (10%) and 9 (18%)-month-old mice. Increase in bax expression might be related to an apoptotic induction which contributes to the HD progression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18468793     DOI: 10.1016/j.neulet.2008.03.062

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Molecular characterization of skeletal muscle atrophy in the R6/2 mouse model of Huntington's disease.

Authors:  Pengxiang She; Zhiyou Zhang; Deanna Marchionini; William C Diaz; Thomas J Jetton; Scot R Kimball; Thomas C Vary; Charles H Lang; Christopher J Lynch
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-04-19       Impact factor: 4.310

Review 2.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

3.  Treadmill exercise enhances spatial learning ability through suppressing hippocampal apoptosis in Huntington's disease rats.

Authors:  Eun-Sang Ji; You-Mi Kim; Mal-Soon Shin; Chang-Ju Kim; Kwang-Sik Lee; Kijeong Kim; Jonglin Ha; Yong-Rak Chung
Journal:  J Exerc Rehabil       Date:  2015-06-30

4.  microRNA-128a dysregulation in transgenic Huntington's disease monkeys.

Authors:  Jannet Kocerha; Yan Xu; Melinda S Prucha; Dongming Zhao; Anthony W S Chan
Journal:  Mol Brain       Date:  2014-06-13       Impact factor: 4.041

Review 5.  Defining the role of the Bcl-2 family proteins in Huntington's disease.

Authors:  J Sassone; A Maraschi; F Sassone; V Silani; A Ciammola
Journal:  Cell Death Dis       Date:  2013-08-15       Impact factor: 8.469

Review 6.  From pathways to targets: understanding the mechanisms behind polyglutamine disease.

Authors:  Jonasz Jeremiasz Weber; Anna Sergeevna Sowa; Tina Binder; Jeannette Hübener
Journal:  Biomed Res Int       Date:  2014-09-21       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.